Home›Trial›NCT06747949

🔬NCT06747949Phase 3RECRUITING

A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)

Study Summary

The primary objective of this study is to evaluate the long-term safety and tolerability of dazodalibep.

Conditions

Sjögren's Syndrome

Interventions / Drugs

View on ClinicalTrials.gov ↗

Sponsor

Study Details

Enrollment844 participants

Primary Completion—

Lead SponsorAmgen

Data Retrieved2026-04-13 18:29:34.157228+00:00

Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.